Etiopathogenesis of Pandu Roga and its Upashayatmaka Study with Yograj Rasayan w.s.r. to RDW (Red blood cell Distribution Width).

Dr Megha Choudhary0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Patientâ??s age between 16 to 60 years, presenting signs and symptoms of Pandu Roga (Anaemia).
•2. Patient having Hb% <11 gm/dL in female and <13 gm/dL in male.
•3. Patient or its attendant is able and willing to provide written informed consent.

•1. Patient suffering with severe anaemia, having Hb% <8 gm/dL in both male and female.
•2. Patient already taking treatment for Anaemia (Pandu Roga).
•3. Pregnant and lactating women.
•4. Patients of Sickle Cell Anaemia and Thalassemia.
•5. Patient having Pandu Roga as complication or having other systemic and/or local disease.
•6. Patient who will have ADR (Adverse Drug Reaction) during the course of the study will be discontinued from the study.

发起方

Dr Megha Choudhary